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 The development of strategies for preventing or retard-
ing growth of cataracts, as alternatives to surgical removal of
mature cataracts, is hindered by our limited understanding of
the mechanisms of lens opacification [1,2].
The transparency of the lens is largely determined by the
properties of crystallins, the family of ocular lens proteins that
are essential for maintaining the proper refractive index gra-
dient needed for the focus of light onto the retina [3]. The
crystallins within the central nucleus of the lens have to re-
main in their native conformation for a lifetime since these
lens fiber cells are post-mitotic and lose their biosynthetic
machinery during the differentiation process. The crystallins
are present at high concentrations (200-450 mg/ml) and ar-
ranged in a closely packed environment [4-6].
The βγ-crystallins are structural proteins of the lens while
the α-crystallins possess molecular chaperone properties and
are able to interact with unfolded proteins in response to stress
and to prevent their aggregation [7-12]. Human γD-crystallin
(HγD-Crys) is the third most abundantly expressed γ-crystal-
lin in the lens and contains 173 amino acids [13,14]. X-ray
crystallographic studies at 1.25 Å resolution showed that the
monomeric protein adopts the characteristic fold of the βγ-
crystallin superfamily [15]. The protein consists of two highly
homologous domains, each composed of two β-sheet Greek
key motifs. The NH2-terminal and COOH-terminal domains
(N-td and C-td) are joined together by a six-amino acid linker
sequence and interact through side chain contacts at the do-
main interface [16]. HγD-Crys possesses differential domain
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Purpose: Amyloid fibrils are associated with a variety of human protein misfolding and protein deposition diseases.
Previous studies have shown that bovine crystallins form amyloid fibers under denaturing conditions and amyloid fibers
accumulate in the lens of mice carrying mutations in crystallin genes. Within differentiating lens fiber cells, crystallins
may be exposed to low pH lysosome compartments. We have investigated whether human γD-crystallin forms amyloid
fibrils in vitro, when exposed to low pH partially denaturing conditions.
Methods: Human γD-crystallin expressed and purified from E. coli, is stable and soluble at 37 °C, pH7, and refolds from
the fully denatured state back to the native state under these conditions. Purified Human γD-crystallin as well as its
isolated NH2- and COOH-terminal domains were incubated at acid pH and subsequently examined by transmission
electron microscopy, absorption spectroscopy in the presence of Congo red, FTIR, and low-angle X-ray scattering.
Results: Incubation of the intact protein at 37 °C in 50 mM acetate buffer pH 3 at 50 mg/ml for 2 days, led to formation
of a viscous, gel-like solution. Examination of negatively stained samples by transmission electron microscopy revealed
linear, non-branching fibrils of variable lengths, with widths ranging from 15 to 35 nm. Incubation with the dye Congo red
generated the spectral red shift associated with dye binding to amyloid. Low-angle X-ray scattering from samples showed
clear meridional reflection at 4.7 Å and a more diffuse reflection on the equator between 10 and 11 Å which is the typical
“cross-β” X-ray fiber diffraction pattern for amyloid fibers. FTIR was used to follow the evolution of the secondary
structure of γD-crystallin with time during incubation of the protein at pH 3. The native protein displayed a major band at
1640 cm-1 that converted during incubation at 37 °C to a band at 1616 cm-1. An additional band at 1689 cm-1 also
appeared with time. The presence of bands in the regions about 1620 cm-1 and about 1680 cm-1 has been attributed to the
formation of intermolecular β-sheet structure that characterizes the fibrillar amyloid motif. The isolated NH2-terminal 1-
82 and COOH-terminal 86-174 domains of HγD-crystallin also formed amyloid fibrils after incubation under the same
conditions, but to a lesser extent than the full length.
Conclusions: HγD-crystallin, as well as its isolated NH2-terminal 1-82 and COOH-terminal 86-174 domains of HγD-
crystallin formed amyloid fibrils upon incubation at acid pH. Investigations of early stages in cataract formation within
the lens will be required to assess whether amyloid fibrils play a role in the initiation of cataract in vivo.
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81stability with the C-td being more stable than the N-td [17].
Equilibrium unfolding/refolding experiments at near-physi-
ologic conditions (pH 7 at 37 °C) demonstrated that the pro-
tein refolds through the sequential structuring of its domains,
with the C-td refolding first [17]. Domain interface residues
subsequently nucleate the refolding of the N-td. Equilibrium
unfolding/refolding experiments also revealed the presence
of a partially folded intermediate probably containing the C-
td in its native conformation and the N-td in its random state
[18].
During cataract development, insoluble aggregates of all
three classes of crystallins accumulate in the lens and lead to
light scattering and loss of lens clarity [19]. Protein precipita-
tion and aggregation might occur by changes of the properties
of crystallins driven by point mutations or age-related post-
translational modifications. There are several types of heredi-
tary cataracts that have been linked to mutations of human
crystallin genes [20-26]. For example in HγD-Crys single
amino acid substitutions are associated with juvenile-onset
cataracts, which may be mediated through spontaneous crys-
tallization or disulfide cross-linked aggregation of the mutants
[27,28]. Lens opacity in these cases is, therefore, associated
with reduction in the solubility of the native state and the for-
mation of solid state complexes [29,30].
For mature-onset cataract, the mechanisms of aggrega-
tion in the aging lens are unlikely to be the same as for the rare
inherited juvenile-onset cataracts. The crystallins of aged and
cataractous lenses present a variety of covalent changes in-
cluding deamidation [31,32], oxidation of methionine and
cysteine residues, backbone cleavage [32], and glycation [33].
The consequence of these modifications may be conforma-
tional changes that alter the crystallin stability, leading to their
denaturation and aggregation. Mature-onset cataract could be
considered as a conformational disorder [22,34] where pro-
tein deposition may be driven by the formation of a partially
folded intermediate [35,36].
At least 20 human protein misfolding and protein deposi-
tion diseases are characterized by the accumulation in differ-
ent tissues of amyloid fibrils. The different pathologies are
believed to arise from a common mechanism [36,37]. In each
case, there is a change in the conformation of a normally folded
protein, which leads to the formation of a partially folded in-
termediate from which amyloid fibrils can be formed by auto
assembly [38-40]. The destabilization of the protein can be
produced by mutations or by the introduction of partially de-
naturing conditions [41]. Amyloid is defined by three features,
namely its tinctorial affinity for the dye Congo red, its un-
branched fibrillar appearance upon analysis by electron mi-
croscopy and its characteristic “cross-β” X-ray diffraction
pattern [36,37,42]. The ability of polypeptide chains to form
amyloid structures is not limited to the disease-associated pro-
teins. Proteins that are not known to be amyloidogenic in vivo
have been shown to undergo self-assembly into fibrils in vitro
[43-49].
Experiments performed under denaturing conditions with
wild-type bovine crystallins demonstrated that all three classes
of proteins are able to form amyloid fibers [50]. In mice
Sandilands and coworkers [52] have shown that mutant trun-
cated forms of the γ-crystallins form inclusions containing fila-
mentous material in the lens that bind Congo red. Further-
more the purified truncated protein formed amyloid fibrils in
vitro [51]. In vitro filament-like formation has also been iden-
tified upon interaction between α-crystallin and βL-crystal-
lin.
Previous studies of the unfolding/refolding pathway of
HγD-Crys in guanidine hydrochloride at 37 °C and pH 7 re-
vealed an in vitro aggregation pathway that proceeded via the
formation of partially folded species [53]. The aggregates were
ordered with filamentous appearance, as seen by atomic force
microscopy and could bind bisANS. In the present studies we
demonstrate that at low pH in vitro γD-crystallin and its iso-
lated domains polymerize into fibrillar aggregates. Using a
combination of Congo red binding, Fourier transform infra-
red spectroscopy, X-ray fiber diffraction and electron micros-
copy approaches we present direct evidence that the fibrils
are amyloid in character.
METHODS
Protein expression and purification:  The HγD-Crys, N-td and
C-td coding sequences were cloned into the pQE.1 plasmid
(Qiagen, Valencia, CA) that added an NH2-terminal 6-His Tag
to the proteins. Bacterial expression and purification of the
recombinant proteins has been described in a previous paper
[17]. Briefly, protein expression was induced at 37 °C by ad-
dition of IPTG. After cell lysis by sonication and removal of
the insoluble material by centrifugation, the supernatant was
loaded onto a Ni-NTA column. The purified proteins were
stored at 4 °C in 10 mM ammonium acetate pH 7 buffer.
Fibril preparation:  To generate fibril samples, the pro-
teins were incubated at 37 °C in 50 mM acetate buffer pH 3 at
5 mg/ml for 2 days. In these conditions the soluble crystallin
proteins aggregated and formed a gel that, as we show in the
Results, consists of amyloid fibrils. Fibril formation can be
induced at pH 3 using a protein concentration as low as 50 µg/
ml.
Electron microscopy:  Samples of the proteins incubated
at 37 °C in 50 mM acetate buffer pH 3 at 5 mg/ml for 2 days,
were diluted to 1 mg/ml and deposited onto glow-discharged
carbon-coated, formvar-filmed copper grids. They were sub-
sequently negatively stained with 1% uranyl acetate and
viewed in a JEOL 1200 transmission electron microscope. The
dimensions of the fibrils were obtained directly from the mi-
crographs.
Congo red staining:  Samples were tested for Congo red
binding by the spectroscopic band-shift assay [54]. Fibrils were
formed as for electron microscopy and diluted into 500 mM
sodium phosphate buffer pH 7 at a 0.5 mg/ml final concentra-
tion. Twenty-five µl of a 100 µM freshly prepared stock solu-
tion of Congo red were added to 475 µl of protein solution
and spectra were recorded from 400 to 600 nm. Absorption
spectra of protein samples in the absence of the dye were also
collected at the same wavelengths, to subtract the scattering
contribution of the aggregates from the spectrum of the dye in
their presence.
©2008 Molecular Vision Molecular Vision 2008; 14:81-9 <http://www.molvis.org/molvis/v14/a10/>
82FTIR measurements:  HgD-Crys was dialyzed against
deuterated 50 mM sodium citrate buffer pH 3 at a concentra-
tion of 20 mg/ml. The sample was placed between two CaF2
windows separated by a 100 mm spacer and placed within a
water-jacketed cell. Sample temperature was held at 37 °C
via a circulating water bath. FTIR spectra were measured on a
Bruker Vector-22 FTIR spectrometer Each spectrum consisted
of an average of 512 scans recorded with 4 cm-1 resolution.
Spectra were measured every 30 min for up to 20 h. A spec-
trum of the blank buffer (also recorded at 37 °C) and of water
vapor were subtracted from the protein absorbance spectrum.
X-ray fiber diffraction:  Each pre-incubated protein fiber
sample was prepared for X-ray diffraction, using two differ-
ent methods. For the first preparation, each protein solution at
a concentration of 5 mg/ml was aspirated into a 0.7 mm diam-
eter siliconized thin wall glass capillary tube. The capillary
tubes were sealed at the narrow end by flame. The wide end
of the capillary was sealed with wax through which a pinhole
was punched using a hot needle. The peptide solution in the
capillary tube (which stood vertically) was then allowed gradu-
ally to dry under ambient temperature and humidity until the
formation of a small, uniform birefringent disk. For the sec-
ond preparation, 5-8 µl of protein fiber sample were depos-
ited between the ends of two glass rods and air-dried. These
samples were loaded into glass capillaries to be examined by
X-ray diffraction. Measurements at room temperature from
the samples were conducted using the Oxford diffraction
Xcalibur PX Ultra system (Oxford Diffraction Ltd.,
Concord,MA) located in the laboratory of Dr. A. Andrew Bohm
(Department of Biochemistry, Tufts University, Boston, MA)
[55]. The CuKα X-ray beam was generated using an Enhance
Ultra, which is a sealed tube-based system incorporating con-
focal multilayer optics. The X-ray beam was monochromated
and the Kβ component was removed by means of the double
bounce within the confocal optics. The X-ray beam was fo-
cused to 0.3 mm x 0.3 mm (full-width at half-maximum width
at detector position). A two-dimensional Onyx CCD detector
(Oxford Diffraction Inc., Concord, MA) was placed 85 mm
from the sample position, covering the scattering range of
Bragg spacing 1.8 Å-54 Å. The sample-to-detector distance
was calibrated by a spherical ylid crystal (C10H10SO4) or a cu-
bic alum crystal according to the information given by manu-
facturer. The active range of the detector was 165 mm, and
the two dimensional image (1024 x 1024 pixels; in 2x2 bin-
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Figure 1. Electron micrographs
of fibrils negatively stained
with 1% uranyl acetate.  Con-
ditions were as follows: A: 5
mg/ml solution of the HγD-
Crys into 50 mM acetate buffer
pH 3 incubated at 37 °C for 2
days, B: 5 mg/ml solution of
the HγD-Crys Ctd into 50 mM
acetate buffer pH 3 incubated
at 37 °C for 2 days, C: 5 mg/
ml solution of the HγD-Crys
Ntd into 50 mM acetate buffer
pH 3 incubated at 37 °C for 2
days, D: 50 µg/ml solution of
the HγD-Crys into 100 mM
sodium citrate pH3 deposited
on the grid after 2 h of incuba-
tion at 37 °C, E: 50 µg/ml so-
lution of the HγD-Crys into
100 mM sodium citrate pH3
deposited on the grid after 6 h
of incubation at 37 °C. The bar
represents 1,000 Å.
83ning) was collected using the software package CrysAlis
(CrysAlis CCD and RED, version 171 [2004], Oxford, UK)
and stored in the compressed image format IMG. Exposure
time was 150-300 s. The diffraction image in the form of JPG
as supplied by CrysAlis RED was translated to TIFF, and then
displayed by NIH image software (developed at the USA Na-
tional Institutes of Health). Using the known Bragg peaks of
the fundamental period of 58.38 Å from silver behenate, the
pixel size of the image was calculated as 121 µm for both the
specimen to film distance of 85 mm.
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Figure 2. Congo red binding to crystallin fibrils.  The spectra of 5
µM Congo red in the absence (blue line) and in the presence (red
line) of fibrils formed by A: HγD-Crys, B: HγD-Crys Ctd, and C:
HγD-Crys Ntd. Before adding the dye, the scattering of the peptide
solutions was recorded and subtracted from the spectrum of the dye
in their presence. Fibrils were formed by incubation of the proteins
at 37 °C in 50 mM acetate buffer pH 3 at 5 mg/ml for 2 days and
subsequently diluted in a 500 mM sodium phosphate buffer pH 7 at
a 0.5 mg/ml concentration.
Figure 3. FTIR spectra as a function of incubation time from 0 to 20
h, at low pH, 37 °C.  A: HγD-Crys, B: HγD-Crys Ctd, and C: HγD-
Crys Ntd. The spectral shift associated with fibril formation is in-
dicative of an increase in the extent of antiparallel β-sheet content.
84RESULTS
Fibril formation as seen by electron microscopy:  Com-
plete wild type HγD-Crys as well as its N-td and C-td do-
mains, were expressed and purified from E. coli strains. All
three preparations were predominantly monomeric when char-
acterized by liquid chromatography. On incubating the three
crystallin proteins, namely HγD-Crys, HγD-Crys N-td and
HγD-Crys C-td, at pH 3 and 37 °C, we observed the forma-
tion of a viscous, gel-like solution after a few hours. This con-
version was associated with the presence of unbranched, long
fibrils as revealed by electron microscopy of negatively stained
samples. Figure 1A-C shows electron micrographs that were
recorded after incubation of 5 mg/ml solutions for 2 days, for
each of the three proteins. The fibrils display typical amyloid
morphology. Their diameter ranged from 15 to 35 nm, similar
to the width of fibrillar structures formed from other
amyloidogenic proteins [39]. These results suggest that at pH
3 the proteins fail to remain correctly folded but instead they
convert to insoluble fibrils through the disruption of their nor-
mal protein conformation.
The morphological development of the fibrils was better
observed at protein concentrations as low as 50 µg/ml. The
process of fibril formation started with small bead-like struc-
tures that have already been described in a variety of
amyloidogenic systems [56-66]. After 6-8 h of incubation these
prefibrillar aggregates could still be seen but in addition, struc-
turally well defined species with fibrillar morphology began
to appear. Figure 1D,E shows representative fields from grids
where a drop of a 50 µg/ml HγD-Crys solution was deposited
after 2 and 6 h of incubation in pH 3 at 37 °C. In high-concen-
tration gel-like samples these oligomeric species were not
present, suggesting their transformation to fibrils.
Congo red binding:  Congo red is a diazo dye that inter-
acts specifically with highly ordered cross β-sheet aggregates.
Congo red birefringence is considered to be one of the three
hallmarks of amyloid. The binding of the dye is revealed by
the spectral difference between fibril-containing solutions and
dye-only solution [54]. The absorbance maximum of the Congo
red incubated in buffer alone increases and shifts to red upon
interaction with ordered fibrils. Figure 2 shows the dye spec-
tra in the presence of aggregates formed from HγD-Crys, HγD-
Crys N-td, and HγD-Crys C-td. For the dye-binding assay the
samples were diluted into pH 7 buffer, which did not solubi-
lize the polymerized protein. The addition of the dye to samples
containing crystallin fibrils produced the characteristic red-
shift expected from interaction with amyloid fibrils.
Secondary structure of the peptides in their fibrillar state
as determined by FTIR:  FTIR is a key method for the study
of the secondary structure of protein aggregates. Using this
technique, we followed the structural transition of HγD-Crys
with time during incubation of the protein in pH 3. The IR
spectrum in the amide I’ region of native HγD-Crys contains a
single broad band, with maximum about 1638 cm-1, consis-
tent with the spectra of other globular, β-sheet rich proteins.
After incubation at pH 3, two new amide I’ bands appear, at
about 1616 and about 1689 cm-1. These bands are character-
istic of the flat, extensive antiparallel β-sheets found in fi-
brous aggregates [67]. The transition from the native spec-
trum to the amyloid-type spectrum was monitored by collec-
tion of spectra at various time points, after shift to acid pH.
The transition has a clear isosbestic point (Figure 3A).
The isolated, native N-td and C-td domain had similar IR
spectra as the full length HγD-Crys. When incubated at pH 3,
the IR spectra of both of these domains also developed new
amide I’ bands at 1616 cm-1 and 1689 cm-1, though to a
smaller extent than seen in the full length HγD-Crys (Figure
3B,C).
X-ray fiber diffraction:  Fibrils produced in acidic condi-
tions were also examined by X-ray fiber diffraction. The re-
corded diffraction patterns for each crystallin protein are shown
in Figure 4. All three of them are characterized by the pres-
ence of a clear meridional reflection at 4.7 Å and a more dif-
fuse reflection on the equator between 10 and 11 Å. These
two reflections are consistent with a β-structure where the β-
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Figure 4. X-ray fiber diffraction from crystallin fibrils.  X-ray fiber diffraction patterns recorded for the A: HγD-Crys, B: HγD-Crys Ctd, and
C: HγD-Crys Ntd fibrils showing the characteristic features associated with the cross-β amyloid motif: an H-bonding 4.7 Å (long arrow)
meridional reflection and an about 10 Å broad reflection (short arrow) on the equator. See experimental procedures for sample preparation.
85sheets are spaced by about 10 Å and arranged parallel to the
fiber axis with their β-strands lying perpendicular to that di-
rection. The 4.7 Å reflection on the meridian arises from the
separation between adjacent strands. The two dominant fea-
tures constitute the “cross-β” diffraction pattern which along
with evidence from electron microscopy and Congo red stain-
ing, has come to be considered as diagnostic for amyloid type
structures [39,68].
DISCUSSION
 The native states of the γ-crystallins are highly soluble and
highly stable, showing little or no tendency to polymerize under
physiologic conditions. The aggregated states populated dur-
ing refolding or unfolding in vitro, as with many other protein
deposition diseases, are formed of partially unfolded species
[17,18,50]. The conformation of the crystallin polypeptide
chains that aggregate during refolding at pH7 in vitro are par-
tially unfolded molecules with the COOH-terminal domain
native-like and the NH2-terminal domain disordered. Within
the lens such partially unfolded crystallins could be generated
by oxidative covalent damage or other environmental stresses.
However, the conformations of the aggregated crystallin chains
within a mature cataract, or the chains that are precursors to
the cataract, have not been characterized.
One aggregated state that is associated with a variety of
human diseases is the amyloid fibril [69]. Though mature cata-
racts do not resemble amyloid plaques, very little is known of
the early stage of cataract formation. Meehan and coworkers
[50] showed that all three classes of bovine crystallins formed
amyloid fibers in vitro, under a particular set of partially de-
naturing conditions. In mice, a truncated form of γ-crystallin
formed inclusions within lens fiber cells that exhibited amy-
loid character, and the purified truncated protein formed amy-
loid fibers in vitro upon dilution from the denatured state [51].
These observations led us to examine the propensity of hu-
man γD-crystallin to form amyloid fibers. Though low pH
environments have not been reported in the lens nucleus, the
differentiating epithelial and fiber cells have lysosomes, which
presumably maintain the low pH denaturing environment
found in other cells.
The results reported here establish that human γD-crys-
tallin forms amyloid fibrils upon incubation at acid pH. Since
the full-length protein is composed of two homologous do-
mains, a domain swapping mechanism would provide one
model for the polymerization process [70]. However, the iso-
lated COOH-terminal domains also formed amyloid fibers in
reasonable yield. This suggests that the Greek key fold itself
reorganizes to form the amyloid structure.
Electron microscopy of cataractous lenses in mature on-
set cataract [71,83,84] do not exhibit the morphological fea-
tures displayed by amyloid plaques [72]. However, cataracts
are generally removed after they have grown to macroscopic
dimensions. The early stages have not been identified within
the lens. It remains possible that the initiating or nucleating
species have a different character than the final bulk aggre-
gate.
Many proteins have been shown to form amyloid fibrils
under physiologic or non-physiologic conditions [36,43,45,46].
Thus the formation of amyloid fibrils in vitro does not estab-
lish that such reactions might be relevant within the lens. How-
ever there is some evidence for the formation of amyloid fi-
bers in both mouse and human lens.
Goldstein and coworkers [73] have reported the presence
of amyloid inclusions in cataracts from individuals with
Alzheimer disease. The supranuclear cataracts colocalized with
enhanced Aβ immunoreactivity and birefringent Congo red
staining. In vitro, Aβ was found to promote lens protein ag-
gregation with curvilinear protofibrillar structure. It also has
been noted that early-onset cataracts and Alzheimer disease
are typical comorbid disorders in adults with Down syndrome
[74]. These results raised the possibility that formation of
amyloid fibers by crystallins or by other proteins within the
lens might stimulate non-amyloid cataract growth.
The lens grows through differentiation of lens epithelial
cells into elongated fiber cells. These elongated cells initially
have the full spectrum of cell organelles including lysosomes.
In fact because of the need to degrade cellular organelles the
outer fiber cells at some stage must have very active proteolytic
apparatus. The activity of the ubiquitin degradation system
has been well documented in lens cells [75]. In the case of
amyloid disease due to mutations affecting transthyretin, Kelly
and coworkers [41,76] have proposed that the amyloidogenic
partially-unfolded intermediate is generated during degrada-
tion in the lysosome. Crystallins targeted to lysosomes due to
oxidative or photo-oxidative damage might generate
amyloidogenic intermediates during breakdown in the lysos-
omes of outer fiber cells. Since amyloid is very stable under
physiologic conditions, these fibers might play a role in nucle-
ating other aggregated states later in the life of the lens.
Recent studies indicate that the relatively disorganized
prefibrillar aggregates have greater toxicity to cells than ma-
ture fibrils [69,77-81] and consequently it has been suggested
that fibril formation could offer, during the early stages of the
diseases, a protection against the toxic prefibrillar intermedi-
ates [59,69]. In the lens, the damaging effects of cataract,
whether or not they include amyloid components, are most
likely due to the direct role of large aggregates in scattering
light and interfering with image formation. However, disrup-
tion of fiber cell organization has been described in catarac-
tous lens [82-84]. Answers to some of these questions will
require studying early stages in the formation of cataracts in
situ, before they are large enough to interfere with lens trans-
parency.
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